Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 3: hypertrophic cardiomyopathy, arrhythmogenic …

BJ Maron, JE Udelson, RO Bonow, RA Nishimura… - Circulation, 2015 - Am Heart Assoc
HCM is the most frequent nontraumatic cause of sudden death in the young1, 2 and a
common genetic heart disease, occurring in at least 1 in 500 people in the general …

Hypertrophic cardiomyopathy and other causes of sudden cardiac death in young competitive athletes, with considerations for preparticipation screening and criteria …

BJ Maron - Cardiology clinics, 2007 - Elsevier
Cardiovascular disease is the most frequent cause of death in young athletes, and
hypertrophic cardiomyopathy (HCM) is the single most common condition responsible for …

How should we screen competitive athletes for cardiovascular disease?

BJ Maron - European heart journal, 2005 - academic.oup.com
The sudden unexpected deaths of young trained athletes are highly visible events which
have a substantial impact on the physician and lay communities. 1 Although initially a focal …

Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 10: the cardiac channelopathies: a scientific …

MJ Ackerman, DP Zipes, RJ Kovacs, BJ Maron - Circulation, 2015 - Am Heart Assoc
The cardiac channelopathies are a collection of primary, genetically mediated heart rhythm
disorders (also referred to as the primary electrical disorders) that are generally associated …

Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 8: coronary artery disease: a scientific statement …

PD Thompson, RJ Myerburg, BD Levine, JE Udelson… - Circulation, 2015 - Am Heart Assoc
Atherosclerotic coronary artery disease (ASCAD) is the leading cause of sudden cardiac
death (SCD) and acute myocardial infarction (AMI) in adult athletes, variously defined as …

Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 5: valvular heart disease: a scientific statement …

RO Bonow, RA Nishimura, PD Thompson… - Circulation, 2015 - Am Heart Assoc
A search of the literature identifies no prospective clinical trials examining the management
of athletes or very physically active, asymptomatic people with abnormal cardiac valves …

Cardiac disease in young trained athletes: insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on …

BJ Maron, A Pelliccia, P Spirito - Circulation, 1995 - Am Heart Assoc
In young competitive athletes, 1 the differential diagnosis between nonpathological changes
in cardiac morphology associated with training (commonly referred to as “athlete's heart”) 2 …

Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy

BJ Maron, KP Carney, HM Lever, JF Lewis… - Journal of the American …, 2003 - jacc.org
Objectives: The goal of this study was to determine the impact of race on identification of
hypertrophic cardiomyopathy (HCM). Background: Sudden death in young competitive …

Does sport participation worsen the clinical course of hypertrophic cardiomyopathy? Clinical outcome of hypertrophic cardiomyopathy in athletes

A Pelliccia, E Lemme, V Maestrini, FM Di Paolo… - Circulation, 2018 - Am Heart Assoc
Hypertrophic cardiomyopathy (HCM) is a heterogeneous disease with respect to its clinical
expression and natural history, with sudden cardiac death (SCD) representing the most …

Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 1: classification of sports: dynamic, static, and …

BD Levine, AL Baggish, RJ Kovacs, MS Link… - Circulation, 2015 - Am Heart Assoc
The “classification of sports” section has been a part of each iteration of the
recommendations for participation in sports and provides a framework by which athletes with …